Overview

• Haemanthus, founded by Billy Evans, aims to revolutionize diagnostics using AI-powered light-detection technology to analyze blood, saliva, and urine samples.
• The startup has raised several million dollars, mostly from friends and family, and is seeking $50 million to advance its prototype and begin animal trials.
• A photo of Haemanthus’ prototype reveals similarities to Theranos’ Edison device, raising concerns about parallels to the failed company.
• Evans plans to start with veterinary diagnostics, leveraging minimal USDA oversight, before transitioning to human health testing.
• Anonymous sources claim Elizabeth Holmes is advising Evans from prison, though the company denies her involvement.